Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Insulin Articles

What are your thoughts on insulin pumps?
Community’s Positive Effect on Diabetes Management
At the Crossroads, I Choose Insulin
Reduced Insulin May Prevent Exercise-Related Hypoglycemia
An Interview With My Husband, Rick
Living With Type 1 Diabetes
Smaller, Lighter OmniPod Earns FDA Approval
We’re Not Bad, We’re Human
The Penalty of Not Being Able to Afford Care Is Too Expensive
Can you please explain the dawn phenomenon, and how best to manage it?
Diabetes Health Reference Charts
Infusion Sets Reference Guide (PDF)
Insulin Pen Needles Reference Guide (PDF)
Lancing Devices Reference Guide (PDF)
Lancing Devices Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Syringes Reference Guide (PDF)
Insulin Pumps Reference Guide (PDF)
Insulin Reference Guide (PDF)
See All Charts…
Insulin Archives
Browse the Insulin Archives
Subscribe to the Medications RSS Feed
Print | Email | Share | Comments (0)

Tip for Type 1s: Consider Lantus

Jun 1, 2005

Long-Acting Insulin Reduces Severe Hypoglycemia

Type 1s who switch from NPH to Lantus (insulin glargine) in multiple daily injection (MDI) regimens significantly reduce severe hypoglycemic episodes without significant weight gain.

A database matched baseline A1C values in 196 subjects with type 1 diabetes receiving more than four MDI per day. Ninety-eight patients transferred from NPH to Lantus, and 98 patients remained on NPH. There was no change in the short-acting insulin dose in either group. The majority of patients were well controlled, with more than 50 percent in both groups having an A1C less than 7%, the goal currently advised by the American Diabetes Association.

Severe hypoglycemia was significantly lower in the Lantus group. The weight gain was significantly higher in the NPH group at the end of the study, with no significant change in the Lantus group.

The study was funded by Sonofi-Aventis, the maker of Lantus.

—Diabetes Technology & Therapeutics, vol. 6, no. 5

Categories: A1c Test, Diabetes, Diabetes, Insulin, Lantus, Low Blood Sugar, Type 1 Issues

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Jun 1, 2005

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.